Redx Pharma
A drug discovery and development company focused on improving the characteristics of existing drug classes to create best-in-class new drugs in two main areas, cancer and infectious disease.
HQ location
Macclesfield, United Kingdom
Website
Launch date
Employees
Enterprise value
$129m
Share price
£0.15 REDX.L
Company register number
Recent deals
loading funding rounds…
CARB-X(exited)
UK Regional Growth Fund(exited)
Jazz Pharmaceuticals(exited)
Sofinnova Partners(exited)
YFM Equity Partners(exited)
The University of Liverpool(exited)
Perscitus(exited)
Jounce Therapeutics(exited)
Redx(exited)
Acceleris Capital(exited)
| GBP | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 2308 % | 82 % | 77 % | 86 % | (78 %) | 197 % | (90 %) |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (186 %) | (134 %) | (190 %) | (81 %) | (696 %) | (207 %) | (3967 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 186 % | (162 %) | (215 %) | (96 %) | (789 %) | (209 %) | (3938 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 133 % | 175 % | 244 % | 153 % | 693 % | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.